According to a new study, tildrakizumab is linked to improved quality of life (QoL) and sleep in patients with moderate-to-severe plaque psoriasis.
New study shows biologics not linked to adverse events in pregnant psoriasis patients
According to a new study, exposure to biologics during pregnancy and conception does not increase the risk of adverse events in pregnant psoriasis patients.
New study shows AD is associated with decreased school performance
According to a new study, adolescents with atopic dermatitis (AD) are more likely to have their school work adversely affected by their skin condition.
Air pollutant exposure, particulate matter linked to more medical visits for AD patients
Air pollution and particulate matter are associated with more medical visits for patients with atopic dermatitis (AD), according to a new study.
Study shows oxymetazoline effective in treating erythema in rosacea patients
According to a new study, oxymetazoline was found to be efficacious in treating rosacea-associated facial erythema.
Online mindfulness training shows improvement in QoL, severity for AD patients
Online mindfulness training has shown improvements in patient quality of life (QoL) and disease severity in Atopic Dermatitis (AD), according to a new study.
Lower limbs are hardest to treat with narrowband-UVB therapy on plaque PsO pts, study shows
According to a new study, lower limbs are the hardest to treat with narrowband-UVB therapy on patients with chronic plaque psoriasis.
Patients, caregivers similarly rate important factors in eczema clinical trial participation
According to a new study, patients and caregivers similarly ranked the importance of factors when choosing whether to participate in eczema clinical trials.
Acitretin associated with increased risk of psychiatric disorders in PsO patients
According to a new study, psoriasis patients being treated with acitretin are at greater risk of developing psychiatric disorders compared to those receiving disease-modifying antirheumatic drugs (DMARDs).
PsO patients treated with methotrexate may have increased skin cancer risk
According to a new study, psoriasis patients treated with methotrexate are almost three times more likely to develop nonmelanoma skin cancer when compared to those not on methotrexate.
HealthMinute.TV 